Global Normal Saline for Parenteral Use Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.

This report studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection

According to APO Research, The global Normal Saline for Parenteral Use market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Normal Saline for Parenteral Use is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Normal Saline for Parenteral Use is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Normal Saline for Parenteral Use is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Normal Saline for Parenteral Use is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Normal Saline for Parenteral Use include Baxter, Pfizer, B. Braun, ICU Medical, Fresenius Kabi, Otsuka, Kelun Group, CR Double-Cran and SSY Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Normal Saline for Parenteral Use, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Normal Saline for Parenteral Use, also provides the sales of main regions and countries. Of the upcoming market potential for Normal Saline for Parenteral Use, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Normal Saline for Parenteral Use sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Normal Saline for Parenteral Use market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Normal Saline for Parenteral Use sales, projected growth trends, production technology, application and end-user industry.


Normal Saline for Parenteral Use Segment by Company

Baxter
Pfizer
B. Braun
ICU Medical
Fresenius Kabi
Otsuka
Kelun Group
CR Double-Cran
SSY Group
Cisen Pharmaceutical
Denis Chem Lab Limited
Shree Krishnakeshav Laboratories
Pharmally International

Normal Saline for Parenteral Use Segment by Type

Flexible Bag
Plastic Bottles
Glass Bottles

Normal Saline for Parenteral Use Segment by Application

Intramuscular Injection
Intravenous Injection
Others

Normal Saline for Parenteral Use Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Normal Saline for Parenteral Use market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Normal Saline for Parenteral Use and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Normal Saline for Parenteral Use.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Normal Saline for Parenteral Use market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Normal Saline for Parenteral Use manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Normal Saline for Parenteral Use in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Normal Saline for Parenteral Use in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Normal Saline for Parenteral Use Market Size, 2020 VS 2024 VS 2031
1.3 Global Normal Saline for Parenteral Use Market Size Estimates and Forecasts (2020-2031)
1.4 Global Normal Saline for Parenteral Use Sales Estimates and Forecasts (2020-2031)
1.5 Global Normal Saline for Parenteral Use Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Normal Saline for Parenteral Use Market Dynamics
2.1 Normal Saline for Parenteral Use Industry Trends
2.2 Normal Saline for Parenteral Use Industry Drivers
2.3 Normal Saline for Parenteral Use Industry Opportunities and Challenges
2.4 Normal Saline for Parenteral Use Industry Restraints
3 Normal Saline for Parenteral Use Market by Manufacturers
3.1 Global Normal Saline for Parenteral Use Revenue by Manufacturers (2020-2025)
3.2 Global Normal Saline for Parenteral Use Sales by Manufacturers (2020-2025)
3.3 Global Normal Saline for Parenteral Use Average Sales Price by Manufacturers (2020-2025)
3.4 Global Normal Saline for Parenteral Use Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Normal Saline for Parenteral Use Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Normal Saline for Parenteral Use Manufacturers, Product Type & Application
3.7 Global Normal Saline for Parenteral Use Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Normal Saline for Parenteral Use Market CR5 and HHI
3.8.2 Global Top 5 and 10 Normal Saline for Parenteral Use Players Market Share by Revenue in 2024
3.8.3 2024 Normal Saline for Parenteral Use Tier 1, Tier 2, and Tier 3
4 Normal Saline for Parenteral Use Market by Type
4.1 Normal Saline for Parenteral Use Type Introduction
4.1.1 Flexible Bag
4.1.2 Plastic Bottles
4.1.3 Glass Bottles
4.2 Global Normal Saline for Parenteral Use Sales by Type
4.2.1 Global Normal Saline for Parenteral Use Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Normal Saline for Parenteral Use Sales by Type (2020-2031)
4.2.3 Global Normal Saline for Parenteral Use Sales Market Share by Type (2020-2031)
4.3 Global Normal Saline for Parenteral Use Revenue by Type
4.3.1 Global Normal Saline for Parenteral Use Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Normal Saline for Parenteral Use Revenue by Type (2020-2031)
4.3.3 Global Normal Saline for Parenteral Use Revenue Market Share by Type (2020-2031)
5 Normal Saline for Parenteral Use Market by Application
5.1 Normal Saline for Parenteral Use Application Introduction
5.1.1 Intramuscular Injection
5.1.2 Intravenous Injection
5.1.3 Others
5.2 Global Normal Saline for Parenteral Use Sales by Application
5.2.1 Global Normal Saline for Parenteral Use Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Normal Saline for Parenteral Use Sales by Application (2020-2031)
5.2.3 Global Normal Saline for Parenteral Use Sales Market Share by Application (2020-2031)
5.3 Global Normal Saline for Parenteral Use Revenue by Application
5.3.1 Global Normal Saline for Parenteral Use Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Normal Saline for Parenteral Use Revenue by Application (2020-2031)
5.3.3 Global Normal Saline for Parenteral Use Revenue Market Share by Application (2020-2031)
6 Global Normal Saline for Parenteral Use Sales by Region
6.1 Global Normal Saline for Parenteral Use Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Normal Saline for Parenteral Use Sales by Region (2020-2031)
6.2.1 Global Normal Saline for Parenteral Use Sales by Region (2020-2025)
6.2.2 Global Normal Saline for Parenteral Use Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Normal Saline for Parenteral Use Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Normal Saline for Parenteral Use Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Normal Saline for Parenteral Use Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Normal Saline for Parenteral Use Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Normal Saline for Parenteral Use Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Normal Saline for Parenteral Use Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Normal Saline for Parenteral Use Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Normal Saline for Parenteral Use Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Normal Saline for Parenteral Use Revenue by Region
7.1 Global Normal Saline for Parenteral Use Revenue by Region
7.1.1 Global Normal Saline for Parenteral Use Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Normal Saline for Parenteral Use Revenue by Region (2020-2025)
7.1.3 Global Normal Saline for Parenteral Use Revenue by Region (2026-2031)
7.1.4 Global Normal Saline for Parenteral Use Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Normal Saline for Parenteral Use Revenue (2020-2031)
7.2.2 North America Normal Saline for Parenteral Use Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Normal Saline for Parenteral Use Revenue (2020-2031)
7.3.2 Europe Normal Saline for Parenteral Use Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Normal Saline for Parenteral Use Revenue (2020-2031)
7.4.2 Asia-Pacific Normal Saline for Parenteral Use Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Normal Saline for Parenteral Use Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Normal Saline for Parenteral Use Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Baxter
8.1.1 Baxter Comapny Information
8.1.2 Baxter Business Overview
8.1.3 Baxter Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Baxter Normal Saline for Parenteral Use Product Portfolio
8.1.5 Baxter Recent Developments
8.2 Pfizer
8.2.1 Pfizer Comapny Information
8.2.2 Pfizer Business Overview
8.2.3 Pfizer Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Pfizer Normal Saline for Parenteral Use Product Portfolio
8.2.5 Pfizer Recent Developments
8.3 B. Braun
8.3.1 B. Braun Comapny Information
8.3.2 B. Braun Business Overview
8.3.3 B. Braun Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 B. Braun Normal Saline for Parenteral Use Product Portfolio
8.3.5 B. Braun Recent Developments
8.4 ICU Medical
8.4.1 ICU Medical Comapny Information
8.4.2 ICU Medical Business Overview
8.4.3 ICU Medical Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 ICU Medical Normal Saline for Parenteral Use Product Portfolio
8.4.5 ICU Medical Recent Developments
8.5 Fresenius Kabi
8.5.1 Fresenius Kabi Comapny Information
8.5.2 Fresenius Kabi Business Overview
8.5.3 Fresenius Kabi Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Fresenius Kabi Normal Saline for Parenteral Use Product Portfolio
8.5.5 Fresenius Kabi Recent Developments
8.6 Otsuka
8.6.1 Otsuka Comapny Information
8.6.2 Otsuka Business Overview
8.6.3 Otsuka Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Otsuka Normal Saline for Parenteral Use Product Portfolio
8.6.5 Otsuka Recent Developments
8.7 Kelun Group
8.7.1 Kelun Group Comapny Information
8.7.2 Kelun Group Business Overview
8.7.3 Kelun Group Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Kelun Group Normal Saline for Parenteral Use Product Portfolio
8.7.5 Kelun Group Recent Developments
8.8 CR Double-Cran
8.8.1 CR Double-Cran Comapny Information
8.8.2 CR Double-Cran Business Overview
8.8.3 CR Double-Cran Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 CR Double-Cran Normal Saline for Parenteral Use Product Portfolio
8.8.5 CR Double-Cran Recent Developments
8.9 SSY Group
8.9.1 SSY Group Comapny Information
8.9.2 SSY Group Business Overview
8.9.3 SSY Group Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 SSY Group Normal Saline for Parenteral Use Product Portfolio
8.9.5 SSY Group Recent Developments
8.10 Cisen Pharmaceutical
8.10.1 Cisen Pharmaceutical Comapny Information
8.10.2 Cisen Pharmaceutical Business Overview
8.10.3 Cisen Pharmaceutical Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Cisen Pharmaceutical Normal Saline for Parenteral Use Product Portfolio
8.10.5 Cisen Pharmaceutical Recent Developments
8.11 Denis Chem Lab Limited
8.11.1 Denis Chem Lab Limited Comapny Information
8.11.2 Denis Chem Lab Limited Business Overview
8.11.3 Denis Chem Lab Limited Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Denis Chem Lab Limited Normal Saline for Parenteral Use Product Portfolio
8.11.5 Denis Chem Lab Limited Recent Developments
8.12 Shree Krishnakeshav Laboratories
8.12.1 Shree Krishnakeshav Laboratories Comapny Information
8.12.2 Shree Krishnakeshav Laboratories Business Overview
8.12.3 Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Product Portfolio
8.12.5 Shree Krishnakeshav Laboratories Recent Developments
8.13 Pharmally International
8.13.1 Pharmally International Comapny Information
8.13.2 Pharmally International Business Overview
8.13.3 Pharmally International Normal Saline for Parenteral Use Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Pharmally International Normal Saline for Parenteral Use Product Portfolio
8.13.5 Pharmally International Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Normal Saline for Parenteral Use Value Chain Analysis
9.1.1 Normal Saline for Parenteral Use Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Normal Saline for Parenteral Use Production Mode & Process
9.2 Normal Saline for Parenteral Use Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Normal Saline for Parenteral Use Distributors
9.2.3 Normal Saline for Parenteral Use Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings